"Follow-up ","Control group n/N (%) ","Intervention group n/N (%) ","Follow-up n/N (%, 95% CI) "
12-month follow-up for cumulative incidence,82/101 (81.19),80/99 (80.81),"162/200 (81.0, 74.86 to 86.19)"
of chlamydia (trial test kits+clinic data),,,
12-month follow-up for trial test kits,80/101 (79.21),80/99 (80.81),"160/200 (80.0, 73.78 to 85.31)"
